- Case Report
Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review
- Federica Pallotti,
- Claire Queffeulou,
- Mathieu Bellal,
- Bastien Jean-Jacques,
- Anne-Claire Gac,
- Valérie Chatelet,
- Annabel Boyer and
- Victor Gueutin
Background: Thrombotic microangiopathies (TMAs) can be induced by drugs. Recent works have indicated proteasome inhibitors, including carfilzomib, as a possible new causative agent. Although the physiopathology and management of carfilzomib-induced T...

